Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

MICHAEL A MORSE

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1588748479
CMS profile
1262085
Location
DURHAM, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$405,108.60

434 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Paying entityAmountRecords
Lexicon Pharmaceuticals, Inc. $76,291.46 80
Exelixis Inc. $76,230.31 81
Ipsen Biopharmaceuticals, Inc $57,697.14 53
Taiho Oncology, Inc. $56,597.61 60
Advanced Accelerator Applications $45,368.02 55
EISAI INC. $26,907.58 33
Genentech USA, Inc. $16,530.78 14
Celgene Corporation $13,219.10 8
Genentech, Inc. $7,744.94 7
Bayer HealthCare Pharmaceuticals Inc. $6,361.78 9
Merck Sharp & Dohme Corporation $5,901.19 9
Agios Pharmaceuticals, Inc. $5,162.74 7
Novartis Pharmaceuticals Corporation $4,881.04 3
Mylan Institutional Inc. $4,575.99 11
Clovis Oncology, Inc. $1,553.50 2
ABIOMED $85.42 2

Page 5 of 9; records 201–250 of 434 matching records. This page contains 50 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

MICHAEL A MORSE

NPI 1588748479 · CMS profile ID 1262085

Allopathic & Osteopathic Physicians / Internal Medicine / Hematology & Oncology

DURHAM, NC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 5 of 9; records 201–250 of 434 matching records. This page contains 50 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1588748479?year=2019&recipient=provider&page=5#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
MICHAEL A MORSE, NPI 1588748479, CMS profile ID 1262085. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 9; records 201–250 of 434 matching records. This page contains 50 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1588748479?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). MICHAEL A MORSE, NPI 1588748479, CMS profile ID 1262085. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 5 of 9; records 201–250 of 434 matching records. This page contains 50 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1588748479?year=2019&recipient=provider&page=5#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
MICHAEL A MORSE, NPI 1588748479, CMS profile ID 1262085, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 5 of 9; records 201–250 of 434 matching records. This page contains 50 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1588748479?year=2019&recipient=provider&page=5#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

434 matching records · $405,108.60 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 434 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 201–250 of 434.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
Exelixis Inc. $271.1407/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555087 CMS
Exelixis Inc. $27.7607/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555089 CMS
Exelixis Inc. $259.4707/27/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555091 CMS
Exelixis Inc. $3,960.0007/26/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555349 CMS
Exelixis Inc. $65.0007/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555351 CMS
Exelixis Inc. $75.0007/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555353 CMS
Exelixis Inc. $30.0007/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555357 CMS
Exelixis Inc. $16.4407/26/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555359 CMS
Exelixis Inc. $288.2207/26/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555363 CMS
Exelixis Inc. $4,290.0007/25/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555185 CMS
Exelixis Inc. $451.4507/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555187 CMS
Exelixis Inc. $21.3807/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555189 CMS
Exelixis Inc. $541.4007/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555191 CMS
Exelixis Inc. $13.0807/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555193 CMS
Exelixis Inc. $13.5107/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555195 CMS
Exelixis Inc. $13.8307/25/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555197 CMS
Exelixis Inc. $6.9207/25/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555355 CMS
Advanced Accelerator Applications $3,930.0007/24/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 708348535 CMS
Lexicon Pharmaceuticals, Inc. $3,078.0007/23/2019 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554659 CMS
EISAI INC. $12.2107/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697009739 CMS
EISAI INC. $767.1207/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697048217 CMS
EISAI INC. $3,125.0007/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697048219 CMS
EISAI INC. $490.4107/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697048221 CMS
EISAI INC. $36.5507/18/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697048223 CMS
EISAI INC. $12.7607/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697048225 CMS
EISAI INC. $15.0007/18/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697048313 CMS
EISAI INC. $1,000.0007/18/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697048315 CMS
Exelixis Inc. $604.8007/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686555361 CMS
Exelixis Inc. $39.9906/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686556627 CMS
Exelixis Inc. $74.6506/21/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686556629 CMS
Exelixis Inc. $270.0706/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686556633 CMS
Exelixis Inc. $30.0006/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686556635 CMS
Exelixis Inc. $12.0006/21/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686556637 CMS
Advanced Accelerator Applications $3,930.0006/20/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 708348423 CMS
Exelixis Inc. $122.8306/20/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686556625 CMS
Ipsen Biopharmaceuticals, Inc $4,240.0006/19/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655991669 CMS
Ipsen Biopharmaceuticals, Inc $115.1806/19/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655991813 CMS
Ipsen Biopharmaceuticals, Inc $343.9406/19/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 655992083 CMS
Advanced Accelerator Applications $200.0006/13/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 708348537 CMS
Exelixis Inc. $5,280.0006/12/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 686556623 CMS
Lexicon Pharmaceuticals, Inc. $12.9806/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554709 CMS
Lexicon Pharmaceuticals, Inc. $32.0206/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554711 CMS
Lexicon Pharmaceuticals, Inc. $423.5006/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554713 CMS
Lexicon Pharmaceuticals, Inc. $175.2306/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554715 CMS
Lexicon Pharmaceuticals, Inc. $21.6306/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554717 CMS
Lexicon Pharmaceuticals, Inc. $34.1606/12/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554719 CMS
Lexicon Pharmaceuticals, Inc. $717.2106/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554721 CMS
Lexicon Pharmaceuticals, Inc. $3,770.0006/12/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554723 CMS
Lexicon Pharmaceuticals, Inc. $28.5206/12/2019 Travel and Lodging No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554725 CMS
Lexicon Pharmaceuticals, Inc. $1,080.0006/11/2019 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 694554707 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $405,108.60 434
PY2020 $151,222.51 117
PY2021 $298,297.92 238
PY2022 $336,707.38 272
PY2023 $335,822.58 254
PY2024 $497,936.08 394
PY2025 $530,149.13 401

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $245,147.98 4
PY2024 Recipient $7,330.00 2
PY2024 Principal investigator $426,972.19 8
PY2023 Recipient $5,150.00 3
PY2023 Principal investigator $174,646.64 5
PY2022 Recipient $1,500.00 1
PY2022 Principal investigator $46,722.03 10
PY2021 Recipient $3,900.00 14
PY2021 Principal investigator $352,960.88 45
PY2020 Recipient $7,736.66 7
PY2020 Principal investigator $653,050.75 32
PY2019 Recipient $525.00 2
PY2019 Principal investigator $1,530,009.80 61

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2025

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

4 records in PY2025

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,507.25 09/26/2025 Non-covered Recipient Entity
DUKE UNIVERSITY SCHOOL OF MEDICINE OFFICE OF CONTINUING MEDICAL EDUCATION
A Phase III, Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study of Durvalumab Monotherapy or in Combination With Bevacizumab as Adjuvant Therapy in Patients with Hepatocellular Carcinoma Who Are at High Risk of Recurrence After Curative Hepatic Resection or Ablation No dispute reported 06/30/2026 1185555800
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $2,108.30 07/17/2025 Non-covered Recipient Entity
Duke University Duke Cancer Institute Sbr Oncology
A Phase 1/2, Openlabel Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1235997617
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $119,259.93 03/13/2025 Non-covered Recipient Entity
Duke Cancer Institute-Duke Univ. Medical Center
A Phase 1/2, Openlabel Study of Nivolumab Monotherapy or Nivolumab Combined with Ipilimumab in Subjects with Advanced or Metastatic Solid Tumors No dispute reported 06/30/2026 1235997645
Principal investigator 1 E.R. Squibb & Sons, L.L.C. $111,272.50 01/21/2025 Non-covered Recipient Entity
Duke University Hospital Pediatric Cystic Fibrosis Program
A Phase III, Randomized, Sponsor Blinded Study of Relatlimab-Nivolumab Fixed Dosed Combination versus Regorafenib or Trifluridine plus Tipiracil for Participants with Later-Lines of Metastatic Colorectal Cancer No dispute reported 06/30/2026 1235997605